APA (7th ed.) Citation

E, D., MV, M., T, D., C, F., M, F., F, G., . . . M, L. (2021). ECMO in COVID-19-prolonged therapy needed? A retrospective analysis of outcome and prognostic factors. Perfusion, 36(6), 582. https://doi.org/10.1177/0267659121995997

Chicago Style (17th ed.) Citation

E, Dreier, et al. "ECMO in COVID-19-prolonged Therapy Needed? A Retrospective Analysis of Outcome and Prognostic Factors." Perfusion 36, no. 6 (2021): 582. https://doi.org/10.1177/0267659121995997.

MLA (9th ed.) Citation

E, Dreier, et al. "ECMO in COVID-19-prolonged Therapy Needed? A Retrospective Analysis of Outcome and Prognostic Factors." Perfusion, vol. 36, no. 6, 2021, p. 582, https://doi.org/10.1177/0267659121995997.